tgen Archives

Pancreatic cancer drug successfully tested by TGen

bioscience

A clinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM-398, given in combination with 5-flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously-treated pancreatic cancer.… Read More →

Gordon named clinical trials medical director

Michael Gordon MD

Michael S. Gordon, MD, one of the greater Phoenix area’s leading medical oncologists and cancer researchers, has been named the new Medical Director for the Virginia G. Piper Cancer Center Clinical Trials program at Scottsdale Healthcare. Dr. Gordon will oversee the center’s internationally recognized Phase I clinical trials program, which is known for its leadership… Read More →

Az Business honors healthcare leaders

10258873_934794563202520_1916243681706580952_o

Each year, Az Business magazine hosts the Healthcare Leadership Awards to honor the women, men and institutions that bring excellence and innovation to Arizona’s healthcare system. Here are the winners and finalists who were chosen by a panel of industry experts and were recognized at the 2014 Healthcare Leadership Awards on Thursday, April 10 at… Read More →

TGen finds clue to stop spread of lung cancer

cancer

Two cell surface receptors might be responsible for the most common form of lung cancer spreading to other parts of the body, according to a study led by the Translational Genomics Research Institute (TGen). The hepatocyte growth factor receptor (HGFR/MET) and fibroblast growth factor-inducible 14 (FN14) are proteins associated with the potential spread of non-small… Read More →

TGen’s Barrett awarded $200,000 research grant

stem.cell

The Pancreatic Cancer Action Network and the American Association for Cancer Research (AACR) awarded a $200,000 grant today to Dr. Michael Barrett of the Translational Genomics Research Institute (TGen). Dr. Barrett, an Associate Professor in TGen’s Clinical Translational Research Division, was one of 14 “outstanding scientists” across the nation named to receive a total of… Read More →

TGen expert honored for cancer research

dan-von-hoff

Dr. Daniel D. Von Hoff, who has been instrumental in developing numerous new cancer treatments, is among this year’s recipients of the Award of Excellence from the Hope Funds for Cancer Research. Dr. Von Hoff, M.D., FACP, who is Physician-In-Chief and Distinguished Professor at the Translational Genomics Research Institute (TGen), and Chief Scientific Officer for… Read More →

TGen recognized as ‘2014 Economic Driver’

Economic Development , 8 honored

The Greater Phoenix Chamber of Commerce has selected the Translational Genomics Research Institute (TGen) for one of its 2014 Impact Awards. TGen was selected among small to medium business in the category of 2014 Economic Driver. “These companies represent the spirit of the entrepreneur — a spirit that truly makes an impact on our community… Read More →

PCH, Barrow and TGen earn NIH grant

brain

Under a new grant from the National Institutes of Health (NIH), Phoenix Children’s Hospital, Barrow Neurological Institute and the Translational Genomics Research Institute (TGen) are studying the role of extracellular RNA (exRNA) as biomarkers in hemorrhagic brain injuries. The study is being funded by a $4 million grant that is part of an international effort… Read More →

SHC’s Von Hoff honored for cancer advances

dan-von-hoff

In association with its 50th anniversary, the American Society of Clinical Oncology (ASCO) has named Daniel D. Von Hoff, M.D., FACP, one of ASCO’s 50 Oncology Luminaries, celebrating 50 doctors who over the past half-century have significantly advanced cancer care. Dr. Von Hoff is Chief Scientific Officer for Scottsdale Healthcare’s Virginia G. Piper Cancer Center… Read More →

LaneTerralever Wins Best in Class

81270218

Phoenix-based LaneTerralever earned three 2013 Interactive Media Awards (IMA) including a Best in Class award for Thunderbird for Good, and two Outstanding Achievement awards – one for Honeywell Aerospace and the other for Translational Genomics Research Institute (TGen). IMA is a competition designed to elevate the standards of excellence on the Internet, and is presented… Read More →

TGen identifies key lung cancer enabler

cancer

Researchers at the Translational Genomics Research Institute (TGen) have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments. Non-small cell lung cancer (NSCLC) makes up about 85 percent of the nearly 160,000 Americans expected to die this year from lung cancer,… Read More →

TGen’s Von Hoff inducted into Joshua Lederberg Society

dan-von-hoff

Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief of the Translational Genomics Research Institute (TGen), was inducted into the Joshua Lederberg Society for his work in developing the drug Abraxane for advanced pancreatic cancer patients. The Lederberg Society is named for the late Dr. Joshua Lederberg, a Nobel Prize laureate and leader in bacterial… Read More →

The Voice of Development: Joyce Grossman, AAED

Joyce Grossman 1 © Lillian Reid

Joyce Grossman became executive director of AAED in 2011. She has a B.A. from the University of California-Davis and a M.P.A. from California State University, Sacramento. Prior to joining AAED, Grossman was a deputy director with the City of Phoenix. She helped in attracting the International Genomics Consortium/Translational Genomics Research Institute to Phoenix. AZRE caught… Read More →

TGen’s Zenhausern is named an NAI fellow

bioscience

Dr. Frederic Zenhausern, a Professor at the Translational Genomics Research Institute (TGen) and developer of a rapid DNA processor, has been named to the Fellows of the National Academy of Inventors (NAI). Zenhausern, Ph.D., MBA, will be inducted into the NAI Fellows by Deputy U.S. Commissioner for Patents Andy Faile, from the U.S. Patent and… Read More →